E. Bonilla, C. Samitt, A. Miranda, A. Hays, G. Salviati et al., Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface, Cell, vol.54, issue.4, pp.447-452, 1988.
DOI : 10.1016/0092-8674(88)90065-7

E. Hoffman, R. Brown, . Jr, and L. Kunkel, Dystrophin: The protein product of the duchenne muscular dystrophy locus, Cell, vol.51, issue.6, pp.919-928, 1987.
DOI : 10.1016/0092-8674(87)90579-4

A. Emery, Population frequencies of inherited neuromuscular diseases???A world survey, Neuromuscular Disorders, vol.1, issue.1, pp.19-29, 1991.
DOI : 10.1016/0960-8966(91)90039-U

S. Moat, D. Bradley, R. Salmon, A. Clarke, and L. Hartley, Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK), European Journal of Human Genetics, vol.34, issue.10, pp.1049-1053, 2013.
DOI : 10.1016/j.bcmd.2011.10.005

V. Dubowitz, CARRIER DETECTION AND GENETIC COUNSELLING IN DUCHENNE DYSTROPHY, Developmental Medicine & Child Neurology, vol.i, issue.3, pp.352-356, 1975.
DOI : 10.1212/WNL.24.5.462

A. Manzur and F. Muntoni, Diagnosis and new treatments in muscular dystrophies, Journal of Neurology, Neurosurgery & Psychiatry, vol.80, issue.7, pp.706-714, 2009.
DOI : 10.1136/jnnp.2008.158329

URL : https://hal.archives-ouvertes.fr/hal-00552718

E. Berardi, D. Annibali, M. Cassano, S. Crippa, and M. Sampaolesi, Molecular and cell-based therapies for muscle degenerations: a road under construction, Frontiers in Physiology, vol.9, p.119, 2014.
DOI : 10.3748/wjg.v9.i7.1567

A. Mauro, SATELLITE CELL OF SKELETAL MUSCLE FIBERS, The Journal of Cell Biology, vol.9, issue.2, pp.493-495, 1961.
DOI : 10.1083/jcb.9.2.493

J. Morgan and T. Partridge, Muscle satellite cells, The International Journal of Biochemistry & Cell Biology, vol.35, issue.8, pp.1151-1156, 2003.
DOI : 10.1016/S1357-2725(03)00042-6

URL : https://hal.archives-ouvertes.fr/pasteur-00181349

I. Kinoshita, J. Vilquin, B. Guérette, I. Asselin, R. Roy et al., Very efficient myoblast allotransplantation in mice under FK506 immunosuppression, Muscle & Nerve, vol.333, issue.12, pp.1407-1415, 1994.
DOI : 10.1038/333466a0

T. Partridge, J. Morgan, G. Coulton, E. Hoffman, and L. Kunkel, Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts, Nature, vol.337, issue.6203, pp.176-179, 1989.
DOI : 10.1038/337176a0

J. Huard, G. Tremblay, S. Verreault, C. Labrecque, and J. Tremblay, Utilization of an Antibody Specific for Human Dystrophin to Follow Myoblast Transplantation in Nude Mice, Cell Transplantation, vol.333, issue.8, pp.113-118, 1993.
DOI : 10.1038/333466a0

J. Huard, S. Verreault, R. Roy, M. Tremblay, and J. Tremblay, High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice., Journal of Clinical Investigation, vol.93, issue.2, pp.586-599, 1994.
DOI : 10.1172/JCI117011

E. Gussoni, G. Pavlath, A. Lanctot, K. Sharma, R. Miller et al., Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation, Nature, vol.356, issue.6368, pp.435-438, 1992.
DOI : 10.1038/356435a0

J. Mendell, J. Kissel, A. Amato, W. King, L. Signore et al., Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy, New England Journal of Medicine, vol.333, issue.13, pp.832-838, 1995.
DOI : 10.1056/NEJM199509283331303

B. Guérette, I. Asselin, J. Vilquin, R. Roy, and J. Tremblay, Lymphocyte infiltration following allo-and xenomyoblast transplantation in mdx mice, Muscle Nerve, vol.18, issue.1, pp.39-51, 1995.

J. Huard, J. Bouchard, R. Roy, F. Malouin, G. Dansereau et al., Human myoblast transplantation: Preliminary results of 4 cases, Muscle & Nerve, vol.333, issue.5, pp.550-560, 1992.
DOI : 10.1042/bst0040053

J. Tremblay, F. Malouin, R. Roy, J. Huard, J. Bouchard et al., Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy, Cell Transplantation, vol.333, issue.2, pp.99-112, 1993.
DOI : 10.1038/333466a0

J. Vilquin, E. Wagner, I. Kinoshita, R. Roy, and J. Tremblay, Successful histocompatible myoblast transplantation in dystrophin- deficient mdx mouse despite the production of antibodies against dystrophin, The Journal of Cell Biology, vol.131, issue.4, pp.975-988, 1995.
DOI : 10.1083/jcb.131.4.975

S. Chirieleison, J. Feduska, R. Schugar, Y. Askew, and B. Deasy, Human Muscle-Derived Cell Populations Isolated by Differential Adhesion Rates: Phenotype and Contribution to Skeletal Muscle Regeneration in Mdx/SCID Mice, Tissue Engineering Part A, vol.18, issue.3-4, pp.3-4232, 2012.
DOI : 10.1089/ten.tea.2010.0553

M. Crisan, S. Yap, L. Casteilla, C. Chen, M. Corselli et al., A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs, Cell Stem Cell, vol.3, issue.3, pp.301-313, 2008.
DOI : 10.1016/j.stem.2008.07.003

A. Dellavalle, M. Sampaolesi, R. Tonlorenzi, E. Tagliafico, B. Sacchetti et al., Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells, Nature Cell Biology, vol.101, issue.3, pp.255-267, 2007.
DOI : 10.1073/pnas.091062498

J. Meng, C. Adkin, S. Xu, F. Muntoni, and J. Morgan, Contribution of Human Muscle-Derived Cells to Skeletal Muscle Regeneration in Dystrophic Host Mice, PLoS ONE, vol.176, issue.15, pp.6-17454
DOI : 10.1371/journal.pone.0017454.s007

J. Meng, S. Chun, R. Asfahani, H. Lochmüller, F. Muntoni et al., Human Skeletal Muscle???derived CD133+ Cells Form Functional Satellite Cells After Intramuscular Transplantation in Immunodeficient Host Mice, Molecular Therapy, vol.22, issue.5, pp.1008-1017, 2014.
DOI : 10.1038/mt.2014.26

M. Minasi, M. Riminucci, D. Angelis, L. Borello, U. Berarducci et al., The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues, Development, vol.129, issue.11, pp.2773-2783, 2002.

Y. Torrente, M. Belicchi, M. Sampaolesi, F. Pisati, M. Meregalli et al., Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle, Journal of Clinical Investigation, vol.114, issue.2, pp.182-195, 2004.
DOI : 10.1172/JCI20325

R. Benchaouir, M. Meregalli, A. Farini, D. Antona, G. Belicchi et al., Restoration of human dystrophin following transplantation of exonskipping-engineered DMD patient stem cells into dystrophic mice, Cell Stem Cell, vol.24, issue.1, pp.646-657, 2007.

M. Sampaolesi, Y. Torrente, A. Innocenzi, R. Tonlorenzi, D. Antona et al., Cell Therapy of ??-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts, Science, vol.301, issue.5632, pp.487-492, 2003.
DOI : 10.1126/science.1082254

M. Sampaolesi, S. Blot, D. Antona, G. Granger, N. Tonlorenzi et al., Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs, Nature, vol.4, issue.7119, pp.574-579, 2006.
DOI : 10.1038/nri1332

H. Oshima, T. Payne, K. Urish, T. Sakai, Y. Ling et al., Differential Myocardial Infarct Repair with Muscle Stem Cells Compared to Myoblasts, Molecular Therapy, vol.12, issue.6, pp.1130-1141, 2005.
DOI : 10.1016/j.ymthe.2005.07.686

Z. Qu, L. Balkir, J. Van-deutekom, P. Robbins, R. Pruchnic et al., Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy, The Journal of Cell Biology, vol.70, issue.5, pp.1257-1267, 1998.
DOI : 10.1038/333466a0

Z. Qu-petersen, B. Deasy, R. Jankowski, M. Ikezawa, J. Cummins et al., Identification of a novel population of muscle stem cells in mice, The Journal of Cell Biology, vol.17, issue.5, pp.851-864, 2002.
DOI : 10.1002/ar.1112

A. Rodriguez, D. Pisani, C. Dechesne, C. Turc-carel, J. Kurzenne et al., Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse, The Journal of Experimental Medicine, vol.90, issue.9, pp.1397-1405, 2005.
DOI : 10.1089/107632701753337681

URL : https://hal.archives-ouvertes.fr/hal-00304039

N. Vieira, M. Valadares, E. Zucconi, M. Secco, C. Bueno et al., Human Adipose-Derived Mesenchymal Stromal Cells Injected Systemically into GRMD Dogs without Immunosuppression are Able to Reach the Host Muscle and Express Human Dystrophin, Cell Transplantation, vol.13, issue.12, pp.1407-1417, 2012.
DOI : 10.1091/mbc.E02-02-0105

Z. Yan, Y. Zhuansun, G. Liu, R. Chen, J. Li et al., Mesenchymal stem cells suppress T cells by inducing apoptosis and through PD-1/B7-H1 interactions, Immunology Letters, vol.162, issue.1, 2014.
DOI : 10.1016/j.imlet.2014.09.013

A. Pt, , pp.248-255

M. François, R. Romieu-mourez, M. Li, and J. Galipeau, Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation, Molecular Therapy, vol.20, issue.1, pp.187-195, 2012.
DOI : 10.1038/mt.2011.189

K. English, R. Tonlorenzi, G. Cossu, and K. Wood, Mesoangioblasts Suppress T Cell Proliferation Through IDO and PGE-2-Dependent Pathways, Stem Cells and Development, vol.22, issue.3, pp.512-523, 2013.
DOI : 10.1089/scd.2012.0386

S. Melief, E. Schrama, M. Brugman, M. Tiemessen, M. Hoogduijn et al., Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages, STEM CELLS, vol.104, issue.9, pp.1980-1991, 2013.
DOI : 10.1073/pnas.0706832104

J. Borel, G. Baumann, I. Chapman, P. Donatsch, A. Fahr et al., In Vivo Pharmacological Effects of Ciclosporin and Some Analogues, Adv Pharmacol, vol.35, pp.115-246, 1996.
DOI : 10.1016/S1054-3589(08)60276-8

B. Kahan, Immunosuppressive therapy, Current Opinion in Immunology, vol.4, issue.5, pp.553-560, 1992.
DOI : 10.1016/0952-7915(92)90025-A

S. Hariharan, C. Johnson, B. Bresnahan, S. Taranto, M. Mcintosh et al., Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996, New England Journal of Medicine, vol.342, issue.9, pp.605-612, 1988.
DOI : 10.1056/NEJM200003023420901

M. Henry, Cyclosporine and tacrolimus (FK506): A comparison of efficacy and safety profiles, Clinical Transplantation, vol.55, issue.3, pp.209-220, 1999.
DOI : 10.1097/00007890-199304000-00020

J. Burke, . Jr, J. Pirsch, E. Ramos, D. Salomon et al., Long-Term Efficacy and Safety of Cyclosporine in Renal-Transplant Recipients, New England Journal of Medicine, vol.331, issue.6, pp.358-363, 1994.
DOI : 10.1056/NEJM199408113310604

O. Wongmekiat and K. Thamprasert, Investigating the protective effects of aged garlic extract on cyclosporin-induced nephrotoxicity in rats, Fundamental and Clinical Pharmacology, vol.131, issue.5, pp.555-62, 2005.
DOI : 10.1016/S0024-3205(02)02475-X

R. Warren and C. Griffiths, Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine, Clinics in Dermatology, vol.26, issue.5, pp.438-447, 2008.
DOI : 10.1016/j.clindermatol.2007.11.006

J. Chi, Y. Zhu, Y. Fu, Y. Liu, X. Zhang et al., Cyclosporin A induces apoptosis in H9c2 cardiomyoblast cells through calcium-sensing receptor-mediated activation of the ERK MAPK and p38 MAPK pathways, Molecular and Cellular Biochemistry, vol.4, issue.1-2, pp.227-236, 2012.
DOI : 10.1096/fj.06-7859rev

Y. Zhu, C. J. Liu, Y. Sun, Y. Fu, Y. Zhang et al., Knockdown of dishevelled-1 attenuates cyclosporine A-induced apoptosis in H9c2 cardiomyoblast cells, Molecular and Cellular Biochemistry, vol.20, issue.3, pp.113-123, 2013.
DOI : 10.1038/sj.onc.1204892

J. Fishman, Infection in Solid-Organ Transplant Recipients, New England Journal of Medicine, vol.357, issue.25, pp.2601-2614, 2007.
DOI : 10.1056/NEJMra064928

M. Bottomley and P. Harden, Update on the long-term complications of renal transplantation, British Medical Bulletin, vol.296, issue.Suppl. 3), pp.117-134, 2013.
DOI : 10.1093/bmb/ldt012

M. Herman, T. Weinstein, A. Korzets, A. Chagnac, Y. Ori et al., Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients, Journal of Laboratory and Clinical Medicine, vol.137, issue.1, p.14, 2001.
DOI : 10.1067/mlc.2001.111469

M. Biring, M. Fournier, D. Ross, and M. Lewis, Cellular adaptations of skeletal muscles to cyclosporine, Journal of Applied Physiology, vol.70, issue.30, pp.1967-1975, 1998.
DOI : 10.1164/ajrccm/145.1.101

J. Fernández-solá, J. Campistol, J. Casademont, J. Grau, and A. Urbano-márquez, Reversible cyclosporin myopathy, The Lancet, vol.335, issue.8685, pp.362-363, 1990.
DOI : 10.1016/0140-6736(90)90658-R

B. Friday, V. Horsley, and G. Pavlath, Calcineurin Activity Is Required for the Initiation of Skeletal Muscle Differentiation, The Journal of Cell Biology, vol.11, issue.3, pp.657-666, 2000.
DOI : 10.1101/gad.13.2.213

O. Hardiman, R. Sklar, R. Brown, and . Jr, Direct effects of cyclosporin A and cyclophosphamide on differentiation of normal human myoblasts in culture, Neurology, vol.43, issue.7, pp.1432-1434, 1993.
DOI : 10.1212/WNL.43.7.1432

F. Hong, J. Lee, J. Song, S. Lee, H. Ahn et al., isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity, The FASEB Journal, vol.16, issue.12, pp.1633-1635, 2002.
DOI : 10.1096/fj.02-0060fje

K. Sakuma, J. Nishikawa, R. Nakao, K. Watanabe, T. Totsuka et al., Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2, Acta Neuropathol, vol.105, issue.3, pp.271-280, 2003.

K. Sakuma, R. Nakao, W. Aoi, S. Inashima, T. Fujikawa et al., Cyclosporin A treatment upregulates Id1 and Smad3 expression and delays skeletal muscle regeneration, Acta Neuropathologica, vol.13, issue.3, pp.269-280, 2005.
DOI : 10.1016/S0002-9440(10)64303-9

K. Rouger, T. Larcher, L. Dubreil, J. Deschamps, L. Guiner et al., Systemic Delivery of Allogenic Muscle Stem Cells Induces Long-Term Muscle Repair and Clinical Efficacy in Duchenne Muscular Dystrophy Dogs, The American Journal of Pathology, vol.179, issue.5, pp.2501-2518, 2011.
DOI : 10.1016/j.ajpath.2011.07.022

URL : https://hal.archives-ouvertes.fr/inserm-00712818

F. Robriquet, A. Lardenois, C. Babarit, T. Larcher, L. Dubreil et al., Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation, PLOS ONE, vol.17, issue.3, p.123336, 2015.
DOI : 10.1371/journal.pone.0123336.s008

URL : https://hal.archives-ouvertes.fr/hal-01222898

K. Honeyman, K. Carville, J. Howell, S. Fletcher, and S. Wilton, Development of a snapback method of single-strand conformation polymorphism analysis for genotyping Golden Retrievers for the X-linked muscular dystrophy allele, Am J Vet Res, vol.60, issue.6, pp.734-737, 1999.

N. Yuhki, T. Beck, R. Stephens, B. Neelam, O. Brien et al., Comparative Genomic Structure of Human, Dog, and Cat MHC: HLA, DLA, and FLA, Journal of Heredity, vol.172, issue.2, pp.390-399, 2007.
DOI : 10.1084/jem.172.2.621

J. Thibaud, A. Monnet, D. Bertoldi, I. Barthélémy, S. Blot et al., Characterization of dystrophic muscle in golden retriever muscular dystrophy dogs by nuclear magnetic resonance imaging, Neuromuscular Disorders, vol.17, issue.7, pp.575-584, 2007.
DOI : 10.1016/j.nmd.2007.03.013

L. Guiner, C. Montus, M. Servais, L. Chérel, Y. François et al., Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients, Molecular Therapy, vol.22, issue.11, pp.1923-1935, 2014.
DOI : 10.1038/mt.2014.151

J. Hare, J. Fishman, G. Gerstenblith, D. Velazquez, D. Zambrano et al., Comparison of Allogeneic vs Autologous Bone Marrow???Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy, JAMA, vol.308, issue.22, pp.2369-2379, 2012.
DOI : 10.1001/jama.2012.25321

A. Baroja-mazo, B. Revilla-nuin, P. Ramírez, and J. Pons, Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation, World Journal of Transplantation, vol.6, issue.1, pp.183-192, 2016.
DOI : 10.1038/nature08097

G. Cossu, S. Previtali, S. Napolitano, M. Cicalese, F. Tedesco et al., Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy, EMBO Molecular Medicine, vol.7, issue.12, pp.1513-1528, 2015.
DOI : 10.15252/emmm.201505636

P. Ventura-aguiar, J. Campistol, and F. Diekmann, Safety of mTOR inhibitors in adult solid organ transplantation, Expert Opinion on Drug Safety, vol.23, issue.6, pp.303-319, 2016.
DOI : 10.1111/j.1399-0012.2010.01232.x

A. Gebler, O. Zabel, and B. Seliger, The immunomodulatory capacity of mesenchymal stem cells, Trends in Molecular Medicine, vol.18, issue.2, pp.128-134, 2012.
DOI : 10.1016/j.molmed.2011.10.004

T. Ichim, D. Alexandrescu, F. Solano, F. Lara, C. Rde et al., Mesenchymal stem cells as anti-inflammatories: Implications for treatment of Duchenne muscular dystrophy, Cellular Immunology, vol.260, issue.2, pp.75-82, 2010.
DOI : 10.1016/j.cellimm.2009.10.006

A. Uccelli, V. Pistoia, and L. Moretta, Mesenchymal stem cells: a new strategy for immunosuppression?, Trends in Immunology, vol.28, issue.5, pp.219-226, 2007.
DOI : 10.1016/j.it.2007.03.001

B. Guérette, D. Skuk, F. Célestin, C. Huard, F. Tardif et al., Prevention by anti-LFA-1 of acute myoblast death following transplantation, J Immunol, vol.159, issue.5, pp.2522-2531, 1997.

S. Villalta, C. Rinaldi, B. Deng, G. Liu, B. Fedor et al., Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype, Human Molecular Genetics, vol.7, issue.6, pp.790-805, 2011.
DOI : 10.1016/j.cmet.2008.04.003

K. Sales, D. Maldonado-pérez, V. Grant, R. Catalano, M. Wilson et al., Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway, Biochim Biophys Acta, issue.12, pp.17931917-1928, 2009.

J. Boyd, M. Divangahi, L. Yahiaoui, D. Gvozdic, S. Qureshi et al., Toll-Like Receptors Differentially Regulate CC and CXC Chemokines in Skeletal Muscle via NF-??B and Calcineurin, Infection and Immunity, vol.74, issue.12, pp.6829-6838, 2006.
DOI : 10.1128/IAI.00286-06

A. Datta, R. David, G. S. Scott, D. Cernuda-morollon, E. Lechler et al., Differential Effects of Immunosuppressive Drugs on T-Cell Motility, American Journal of Transplantation, vol.164, issue.12, pp.2871-2883, 2006.
DOI : 10.1111/j.1600-065X.1999.tb01374.x

T. Chen, J. Guo, M. Yang, C. Han, M. Zhang et al., Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression, Blood, vol.103, issue.2, pp.413-421, 2004.
DOI : 10.1182/blood-2003-07-2412

DOI : 10.1097/00007890-198306000-00014

Y. Nitahara-kasahara, H. Hayashita-kinoh, S. Ohshima-hosoyama, H. Okada, M. Wada-maeda et al., Long-term Engraftment of Multipotent Mesenchymal Stromal Cells That Differentiate to Form Myogenic Cells in Dogs With Duchenne Muscular Dystrophy, Molecular Therapy, vol.20, issue.1, pp.168-177, 2012.
DOI : 10.1038/mt.2011.181

M. Valadares, J. Gomes, G. Castello, A. Assoni, M. Pellati et al., Human Adipose Tissue Derived Pericytes Increase Life Span in Utrn tm1Ked Dmd mdx /J Mice, Stem Cell Reviews and Reports, vol.3, issue.6, pp.830-840, 2014.
DOI : 10.1038/ncomms1611

N. Vieira, C. Bueno, . Jr, V. Brandalise, L. Moraes et al., Dystrophic Mice Express a Significant Amount of Human Muscle Proteins Following Systemic Delivery of Human Adipose-Derived Stromal Cells Without Immunosuppression, Stem Cells, vol.25, issue.9, pp.2391-2398, 2008.
DOI : 10.1212/WNL.53.5.1119

K. Flanigan, K. Campbell, L. Viollet, W. Wang, A. Gomez et al., Anti-Dystrophin T Cell Responses in Duchenne Muscular Dystrophy: Prevalence and a Glucocorticoid Treatment Effect, Human Gene Therapy, vol.24, issue.9, pp.797-806, 2013.
DOI : 10.1089/hum.2013.092

J. Mendell, K. Campbell, L. Rodino-klapac, Z. Sahenk, C. Shilling et al., Dystrophin Immunity in Duchenne's Muscular Dystrophy, New England Journal of Medicine, vol.363, issue.15, pp.1429-1437, 2010.
DOI : 10.1056/NEJMoa1000228

K. English, A. French, and K. Wood, Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?, Cell Stem Cell, vol.7, issue.4, pp.431-442, 2010.
DOI : 10.1016/j.stem.2010.09.009

G. Ren, X. Zhao, L. Zhang, J. Zhang, L. Huillier et al., Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression, The Journal of Immunology, vol.184, issue.5, pp.2321-2328, 2010.
DOI : 10.4049/jimmunol.0902023